Leaf Pharmaceuticals News Today

The The The The The In addition, GW Pharmaceuticals plc (NASDAQ:GWPH) published positive results for its Phase 3 clinical trial of Epidiolex oral solution in seizures related to tuberous sclerosis complex in JAMA Neurology. Epidiolex is the first FDA-authorized CBD medicine for children with severe forms of epilepsy. The medicine was first approved for treatments of seizures connected to Lennox-Gastaut syndrome and Dravet syndrome. Michigan Gov. Gretchen Whitmer commuted the sentence of...

The U.S. Food and Drug Administration warned five companies on Tuesday to stop selling CBD products the agency said violate the Federal Food, Drug, and Cosmetic Act. The regulatory body issued warning letters to Bee Delightful; G&L Wellness (C Better Daily); New Leaf Pharmaceuticals; NextL3vel Services Group, LLC, doing business as This Stuff Is Good For You; and Wellness BioSciences. None of the products addressed in the letters underwent its drug approval process, the FDA said.  The conc...

FDA issues warning letters to companies illegally selling unapproved CBD products Today, the U.S. Food and Drug Administration issued five warning letters to companies for selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). All five warning letters address the illegal marketing of unapproved CBD products claiming to treat medical conditions. The warning letters include CBD products that are especially concerning from a public h...